4.3 Article

Powerful Set-Based Gene-Environment Interaction Testing Framework for Complex Diseases

Journal

GENETIC EPIDEMIOLOGY
Volume 39, Issue 8, Pages 609-618

Publisher

WILEY-BLACKWELL
DOI: 10.1002/gepi.21908

Keywords

G x E screening statistics; eSBERUA; rare variants; GWAS

Funding

  1. NCI NIH HHS [K05 CA152715, R21 CA191312, P01 CA053996, P30 CA015704, R01 CA059045, U01 CA137088, U01 CA164930] Funding Source: Medline
  2. NIA NIH HHS [R01 AG014358] Funding Source: Medline
  3. NIH HHS [S10 OD020069] Funding Source: Medline

Ask authors/readers for more resources

Identification of gene-environment interaction (G x E) is important in understanding the etiology of complex diseases. Based on our previously developed Set Based gene EnviRonment InterAction test (SBERIA), in this paper we propose a powerful framework for enhanced set-based G x E testing (eSBERIA). The major challenge of signal aggregation within a set is how to tell signals from noise. eSBERIA tackles this challenge by adaptively aggregating the interaction signals within a set weighted by the strength of the marginal and correlation screening signals. eSBERIA then combines the screening-informed aggregate test with a variance component test to account for the residual signals. Additionally, we develop a case-only extension for eSBERIA (coSBERIA) and an existing set-based method, which boosts the power not only by exploiting the G-E independence assumption but also by avoiding the need to specify main effects for a large number of variants in the set. Through extensive simulation, we show that coSBERIA and eSBERIA are considerably more powerful than existing methods within the case-only and the case-control method categories across a wide range of scenarios. We conduct a genome-wide G x E search by applying our methods to Illumina HumanExome Beadchip data of 10,446 colorectal cancer cases and 10,191 controls and identify two novel interactions between nonsteroidal anti-inflammatory drugs (NSAIDs) and MINK1 and PTCHD3. (C) 2015 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available